HK1126123A1 - Agent for prevention and treatment of acute renal failure - Google Patents
Agent for prevention and treatment of acute renal failureInfo
- Publication number
- HK1126123A1 HK1126123A1 HK09104504.2A HK09104504A HK1126123A1 HK 1126123 A1 HK1126123 A1 HK 1126123A1 HK 09104504 A HK09104504 A HK 09104504A HK 1126123 A1 HK1126123 A1 HK 1126123A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prevention
- agent
- treatment
- renal failure
- acute renal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005362579 | 2005-12-16 | ||
PCT/JP2006/325054 WO2007069727A1 (ja) | 2005-12-16 | 2006-12-15 | 急性腎不全の予防または治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1126123A1 true HK1126123A1 (en) | 2009-08-28 |
Family
ID=38163029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09104504.2A HK1126123A1 (en) | 2005-12-16 | 2009-05-18 | Agent for prevention and treatment of acute renal failure |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080319038A1 (ko) |
EP (1) | EP1961420B1 (ko) |
JP (1) | JP5107053B2 (ko) |
KR (1) | KR101350226B1 (ko) |
CN (1) | CN101325952B (ko) |
AU (1) | AU2006325947B2 (ko) |
CA (1) | CA2633481C (ko) |
DK (1) | DK1961420T3 (ko) |
ES (1) | ES2393271T3 (ko) |
HK (1) | HK1126123A1 (ko) |
PL (1) | PL1961420T3 (ko) |
WO (1) | WO2007069727A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2415825A1 (en) | 2008-10-02 | 2012-02-08 | LG Chem, Ltd. | Optical fim and method of preparing same |
JP5212849B2 (ja) | 2010-01-14 | 2013-06-19 | 株式会社三和化学研究所 | 眼内血管新生及び/又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬 |
EP2565196A4 (en) | 2010-04-28 | 2014-03-26 | Sanwa Kagaku Kenkyusho Co | PROPHYLACTIC OR THERAPEUTIC MEDICINE FOR INTERNAL EAR DISORDERS |
JP2015110525A (ja) * | 2012-04-02 | 2015-06-18 | 株式会社三和化学研究所 | 歯肉炎の予防又は治療のための医薬 |
US11426386B2 (en) | 2014-12-05 | 2022-08-30 | Case Western Reserve University | Compositions and methods of modulating S-nitrosylation |
AU2015357489A1 (en) | 2014-12-05 | 2017-07-06 | Case Western Reserve University | Compositions and methods of modulating S-nitrosylation |
CN118512442A (zh) | 2017-09-25 | 2024-08-20 | 卡斯西部储备大学 | 降低血清胆固醇和pcsk9的组合物和方法 |
WO2020005938A1 (en) | 2018-06-25 | 2020-01-02 | Case Western Reserve University | Compositions and methods for treating tissue injury |
US11518748B2 (en) | 2018-09-21 | 2022-12-06 | Case Western Reserve University | Aldoketo reductase inhibitors and uses thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
EP0264586B1 (en) * | 1986-08-28 | 1991-04-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes |
US5164391A (en) * | 1989-09-20 | 1992-11-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes and circulatory diseases |
JP2997892B2 (ja) * | 1990-10-05 | 2000-01-11 | 株式会社三和化学研究所 | ヒダントイン誘導体を有効成分とする循環器系疾患の予防及び治療剤 |
JP2997894B2 (ja) | 1990-11-07 | 2000-01-11 | 株式会社三和化学研究所 | 循環器系疾患の予防及び治療剤 |
JP3267698B2 (ja) | 1992-10-27 | 2002-03-18 | 株式会社三和化学研究所 | ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤 |
JPH07242547A (ja) | 1994-03-02 | 1995-09-19 | Sanwa Kagaku Kenkyusho Co Ltd | 糖尿病性単純網膜症の進行阻止剤乃至治療剤 |
JP3603129B2 (ja) | 1994-12-28 | 2004-12-22 | 株式会社三和化学研究所 | 糖尿病性角膜症の治療剤 |
IL120264A0 (en) * | 1996-02-29 | 1997-06-10 | Pfizer | Method of reducing tissue damage associated with non-cardiac ischemia |
US6426341B1 (en) * | 1999-06-30 | 2002-07-30 | Pfizer Inc. | Treatment for diabetic complications |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
WO2003013543A1 (en) | 2001-08-08 | 2003-02-20 | Genomed, Llc | Treatment or prevention of acute renal failure |
TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
WO2003105864A1 (en) * | 2002-06-13 | 2003-12-24 | Board Of Regents, The University Of Texas System | Methods and compositions involving aldose reductase inhibitors |
JP2004300153A (ja) * | 2003-03-20 | 2004-10-28 | Kiyoshi Kurokawa | 蛋白修飾物生成抑制剤 |
US20070060533A1 (en) * | 2003-10-24 | 2007-03-15 | Meiji Seika Kaisha Ltd. | Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor |
AU2005207906B2 (en) * | 2004-01-30 | 2009-10-22 | Sanwa Kagaku Kenkyusho Co., Ltd. | Preventive or therapeutic agent for diabetic maculopathy |
CN1921853A (zh) | 2004-02-20 | 2007-02-28 | 株式会社三和化学研究所 | 重度糖尿病性视网膜病的预防或治疗剂 |
-
2006
- 2006-12-15 CA CA2633481A patent/CA2633481C/en not_active Expired - Fee Related
- 2006-12-15 WO PCT/JP2006/325054 patent/WO2007069727A1/ja active Application Filing
- 2006-12-15 JP JP2007550244A patent/JP5107053B2/ja not_active Expired - Fee Related
- 2006-12-15 EP EP06834797A patent/EP1961420B1/en not_active Not-in-force
- 2006-12-15 AU AU2006325947A patent/AU2006325947B2/en not_active Ceased
- 2006-12-15 CN CN2006800466289A patent/CN101325952B/zh not_active Expired - Fee Related
- 2006-12-15 ES ES06834797T patent/ES2393271T3/es active Active
- 2006-12-15 KR KR1020087016787A patent/KR101350226B1/ko not_active IP Right Cessation
- 2006-12-15 PL PL06834797T patent/PL1961420T3/pl unknown
- 2006-12-15 DK DK06834797.0T patent/DK1961420T3/da active
-
2008
- 2008-06-16 US US12/139,787 patent/US20080319038A1/en not_active Abandoned
-
2009
- 2009-05-18 HK HK09104504.2A patent/HK1126123A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP5107053B2 (ja) | 2012-12-26 |
CA2633481C (en) | 2013-12-17 |
KR20080097400A (ko) | 2008-11-05 |
ES2393271T3 (es) | 2012-12-19 |
EP1961420A1 (en) | 2008-08-27 |
CN101325952A (zh) | 2008-12-17 |
US20080319038A1 (en) | 2008-12-25 |
WO2007069727A1 (ja) | 2007-06-21 |
CN101325952B (zh) | 2012-02-08 |
EP1961420A4 (en) | 2010-12-15 |
JPWO2007069727A1 (ja) | 2009-05-28 |
EP1961420B1 (en) | 2012-07-25 |
PL1961420T3 (pl) | 2012-12-31 |
AU2006325947A1 (en) | 2007-06-21 |
AU2006325947B2 (en) | 2011-09-01 |
KR101350226B1 (ko) | 2014-01-13 |
CA2633481A1 (en) | 2007-06-21 |
DK1961420T3 (da) | 2012-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1126123A1 (en) | Agent for prevention and treatment of acute renal failure | |
EP2004630A4 (en) | 2-AMINOPYRIMIDIN-4-ONES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF PATHOLOGIES RELATED TO PROTEIN A | |
LT1921077T (lt) | Agentas, skirtas miego sutrikimo gydymui ir (arba) prevencijai | |
ZA200707472B (en) | Diosmetin derivatives for the treatment and prevention of thrombotic pathologies | |
ZA200709727B (en) | Compounds and methods for the treatment of prevention of flavivirus infections | |
EP2083886A4 (en) | SEQUENCE FORMATION OF VASCULAR ACCESS DEVICE IN CONTACT WITH BLOOD AND PREVENTION OF EXPOSURE | |
GB0610350D0 (en) | prevention and/or treatment of neuodegenerative disorders | |
PT2520295T (pt) | Métodos para prevenir e tratar a mucosite | |
EP1950209A4 (en) | TREATMENT AGENT FOR CIRCULATORY INSUFFICIENCY | |
IL187565A0 (en) | Compositions and methods for the treatment or prevention of chemoresistant neoplasia | |
EP1884238A4 (en) | AGENTS WITH OBESITY ACTIVITY AND OBESITY INHIBITION PROCEDURE | |
EP1905452A4 (en) | AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA | |
IL207325A0 (en) | Agent for regeneration and/or protection of nerves | |
IL183520A0 (en) | Preventive or therapeutic agent for sleep disorder | |
IL197766A0 (en) | Use of oritavancin for the prevention and treatment of anthrax | |
ZA200709561B (en) | Agent for prophylaxis and treatment of pancreatitis | |
EP2061484A4 (en) | TREATMENT, PREVENTION AND REVERSAL OF ALCOHOL-INDUCED LIVER DISEASES | |
EP1953164A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST FUNCTIONAL ENDURANCE | |
IL197533A0 (en) | Composition for the treatment and/or prevention of fire blight | |
EP1959982A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING AND / OR TREATING PANCREATITIS | |
IL194463A0 (en) | Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound | |
IL196983A0 (en) | Treatment and prevention of intestinal fibrosis | |
EP1857119A4 (en) | AGENT FOR THE PREVENTION / TREATMENT OF NEURODEGENERATIVE DISEASE | |
EP1776956A4 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA | |
IL200377A (en) | Causes the prevention, treatment and / or symptom relief of dysuria and its uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151215 |